BIOT — Bioter SA Income Statement
0.000.00%
Last trade - 00:00- €3.48m
- €187.34m
- €0.50m
Annual income statement for Bioter SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.25 | 0.228 | 0.246 | 0.252 | 0.499 |
| Cost of Revenue | |||||
| Gross Profit | -3.73 | -1.45 | -0.935 | -0.015 | -0.048 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.74 | -16.7 | 0.197 | 0.188 | 2.35 |
| Operating Profit | -2.49 | 16.9 | 0.049 | 0.064 | -1.85 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.96 | 6.94 | -8.8 | -9.45 | -12 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.98 | 5.92 | -8.82 | -9.66 | -11.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.89 | 6.06 | -8.81 | -9.68 | -11.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.89 | 6.06 | -8.81 | -9.68 | -11.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.532 | 0.345 | -0.539 | -0.606 | -0.698 |